Breast cancer, breast cancer-directed radiation therapy and risk of hypothyroidism: A systematic review and meta-analysis

• Published in: Breast (Edinburgh) Vol. 68; pp. 216 - 224
• Main Authors: Solmunde, Elisabeth, Falstie-Jensen, Anne Mette, Lorenzen, Ebbe L., Ewertz, Marianne, Reinertsen, Kristin V., Dekkers, Olaf M., Cronin-Fenton, Deirdre P.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.04.2023; Elsevier
• Subjects: Breast cancer; Breast Neoplasms - pathology; Breast Neoplasms - radiotherapy; Cohort Studies; Female; Humans; Hypothyroidism; Hypothyroidism - epidemiology; Hypothyroidism - etiology; Meta-analysis; Radiation therapy; Review; Treatment late effects; Treatment late effects; Breast cancer; Radiation therapy; Hypothyroidism; Meta-analysis
• ISSN: 0960-9776; 1532-3080; 1532-3080
• DOI: 10.1016/j.breast.2023.02.008

Breast cancer and breast cancer-directed radiation therapy (RT) may increase the risk of late effects, such as hypothyroidism. We conducted a systematic review and meta-analysis to investigate the association between breast cancer, RT, and risk of hypothyroidism in breast cancer survivors. Through February 2022, we searched PubMed, EMBASE, and references of relevant articles, to identify papers on breast cancer and breast cancer-directed RT and subsequent risk of hypothyroidism. Articles were screened by title and abstract and reviewed for eligibility. We used a pre-formed data extraction sheet and identified key design elements that could potentially introduce bias. The main outcome was the confounder-adjusted relative risk (RR) of hypothyroidism in breast cancer survivors versus women without breast cancer, and in breast cancer survivors according to the receipt of RT to the supraclavicular lymph nodes. We used a random-effects model to calculate pooled RRs and associated 95% confidence intervals (95% CI). From 951 papers screened by title and abstract, 34 full-text papers were reviewed for eligibility. We included 20 studies published between 1985 and 2021–19 were cohort studies. Compared with women without breast cancer, the pooled RR of hypothyroidism in breast cancer survivors was 1.48 (95% CI: 1.17, 1.87), with highest risk associated with RT to the supraclavicular region (RR = 1.69, 95% CI: 1.16, 2.46). The most important limitations of the studies were small sample size yielding estimates with low precision, and lack of data on potential confounders. Breast cancer and radiation therapy to the supraclavicular lymph nodes is associated with an increased risk of hypothyroidism. •Breast cancer survivors have an increased risk of hypothyroidism.•Radiation therapy to the supraclavicular lymph nodes further increases this risk.•The thyroid gland may be an organ at risk in breast cancer patients.•Using volume-based delineation may spare the thyroid gland from radiation damage.